These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36424090)

  • 1. Challenges in progressing cell therapies to the clinic for Huntington's disease: A review of the progress made with pluripotent stem cell derived medium spiny neurons.
    Garcia Jareño P; Bartley OJM; Precious SV; Rosser AE; Lelos MJ
    Int Rev Neurobiol; 2022; 166():1-48. PubMed ID: 36424090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell Replacement Therapy for Huntington's Disease.
    Monk R; Connor B
    Adv Exp Med Biol; 2020; 1266():57-69. PubMed ID: 33105495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular therapy and induced neuronal replacement for Huntington's disease.
    Benraiss A; Goldman SA
    Neurotherapeutics; 2011 Oct; 8(4):577-90. PubMed ID: 21971961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell Reprogramming to Model Huntington's Disease: A Comprehensive Review.
    Monk R; Connor B
    Cells; 2021 Jun; 10(7):. PubMed ID: 34206228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pluripotent stem cell-derived neurons for transplantation in Huntington's disease.
    Li M; Rosser AE
    Prog Brain Res; 2017; 230():263-281. PubMed ID: 28552232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. hESC-derived striatal progenitors grafted into a Huntington's disease rat model support long-term functional motor recovery by differentiating, self-organizing and connecting into the lesioned striatum.
    Schellino R; Besusso D; Parolisi R; Gómez-González GB; Dallere S; Scaramuzza L; Ribodino M; Campus I; Conforti P; Parmar M; Boido M; Cattaneo E; Buffo A
    Stem Cell Res Ther; 2023 Jul; 14(1):189. PubMed ID: 37507794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a place for human fetal-derived stem cells for cell replacement therapy in Huntington's disease?
    Precious SV; Zietlow R; Dunnett SB; Kelly CM; Rosser AE
    Neurochem Int; 2017 Jun; 106():114-121. PubMed ID: 28137534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.
    Zhang H; Li Q; Graham RK; Slow E; Hayden MR; Bezprozvanny I
    Neurobiol Dis; 2008 Jul; 31(1):80-8. PubMed ID: 18502655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manifestation of Huntington's disease pathology in human induced pluripotent stem cell-derived neurons.
    Nekrasov ED; Vigont VA; Klyushnikov SA; Lebedeva OS; Vassina EM; Bogomazova AN; Chestkov IV; Semashko TA; Kiseleva E; Suldina LA; Bobrovsky PA; Zimina OA; Ryazantseva MA; Skopin AY; Illarioshkin SN; Kaznacheyeva EV; Lagarkova MA; Kiselev SL
    Mol Neurodegener; 2016 Apr; 11():27. PubMed ID: 27080129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic Analysis of Huntington's Disease Medium Spiny Neurons Identifies Alterations in Lipid Droplets.
    Tshilenge KT; Aguirre CG; Bons J; Gerencser AA; Basisty N; Song S; Rose J; Lopez-Ramirez A; Naphade S; Loureiro A; Battistoni E; Milani M; Wehrfritz C; Holtz A; Hetz C; Mooney SD; Schilling B; Ellerby LM
    Mol Cell Proteomics; 2023 May; 22(5):100534. PubMed ID: 36958627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell transplantation for Huntington's diseases.
    Choi KA; Choi Y; Hong S
    Methods; 2018 Jan; 133():104-112. PubMed ID: 28867501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of human stem cells in Huntington disease modeling and translational research.
    Golas MM; Sander B
    Exp Neurol; 2016 Apr; 278():76-90. PubMed ID: 26826449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Producing striatal phenotypes for transplantation in Huntington's disease.
    Precious SV; Rosser AE
    Exp Biol Med (Maywood); 2012 Apr; 237(4):343-51. PubMed ID: 22490511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of pluripotent stem cells into striatal projection neurons: a pure MSN fate may not be sufficient.
    Reddington AE; Rosser AE; Dunnett SB
    Front Cell Neurosci; 2014; 8():398. PubMed ID: 25520619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of human 3D striato-nigral assembloids to recapitulate medium spiny neuronal projection defects in Huntington's disease.
    Wu S; Hong Y; Chu C; Gan Y; Li X; Tao M; Wang D; Hu H; Zheng Z; Zhu Q; Han X; Zhu W; Xu M; Dong Y; Liu Y; Guo X
    Proc Natl Acad Sci U S A; 2024 May; 121(22):e2316176121. PubMed ID: 38771878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The difficulty to model Huntington's disease in vitro using striatal medium spiny neurons differentiated from human induced pluripotent stem cells.
    Le Cann K; Foerster A; Rösseler C; Erickson A; Hautvast P; Giesselmann S; Pensold D; Kurth I; Rothermel M; Mattis VB; Zimmer-Bensch G; von Hörsten S; Denecke B; Clarner T; Meents J; Lampert A
    Sci Rep; 2021 Mar; 11(1):6934. PubMed ID: 33767215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. hPSC-Derived Striatal Cells Generated Using a Scalable 3D Hydrogel Promote Recovery in a Huntington Disease Mouse Model.
    Adil MM; Gaj T; Rao AT; Kulkarni RU; Fuentes CM; Ramadoss GN; Ekman FK; Miller EW; Schaffer DV
    Stem Cell Reports; 2018 May; 10(5):1481-1491. PubMed ID: 29628395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell therapy and cellular engineering for treatment of neuronal dysfunction in Huntington's disease.
    Choi KA; Hwang I; Park HS; Oh SI; Kang S; Hong S
    Biotechnol J; 2014 Jul; 9(7):882-94. PubMed ID: 24827816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Tissue Preparation and Donor Age on Striatal Graft Morphology in the Mouse.
    Harrison DJ; Roberton VH; Vinh NN; Brooks SP; Dunnett SB; Rosser AE
    Cell Transplant; 2018 Feb; 27(2):230-244. PubMed ID: 29637815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced Pluripotent Stem Cells in Huntington's Disease: Disease Modeling and the Potential for Cell-Based Therapy.
    Liu L; Huang JS; Han C; Zhang GX; Xu XY; Shen Y; Li J; Jiang HY; Lin ZC; Xiong N; Wang T
    Mol Neurobiol; 2016 Dec; 53(10):6698-6708. PubMed ID: 26659595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.